Market Tracker

03/27 6:01pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Mar 27
 +1.46 / +1.20%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.


1 month-0.02% 3 years+33.28%
3 months+13.74% 5 years+27.03%
1 year+40.35% Since inception+19.10%
Data through 03/28/2015

Quote Details

Previous close$121.95
Open day’s range122.06 – 123.59
Net asset value (NAV)123.40 (03/27/2015)
Daily volume48,373
Average volume (3 months)118,999
Data as of 3:59pm ET, 03/27/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+27.03%+22.29%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.741.51
Net assets$1.1B$1.7B
Average market cap$8.0B$32.9B
Average P/E30.026.3
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
HZNP Horizon Pharma PLC4.37%
SLXP Salix Pharmaceuticals Ltd4.11%
DEPO Depomed Inc3.92%
HSP Hospira Inc3.92%
LCI Lannett Company Inc3.87%
THRX Theravance Inc3.65%
AKRX Akorn Inc3.53%
IPXL Impax Laboratories Inc3.50%
PCRX Pacira Pharmaceuticals Inc3.41%
ENDP Endo International PLC3.37%